We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$223M
AUM Growth
-$41.4M
Cap. Flow
-$38.1M
Cap. Flow %
-17.06%
Top 10 Hldgs %
11%
Holding
420
New
44
Increased
50
Reduced
231
Closed
47

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$2.06M
2
PBR icon
Petrobras
PBR
+$2M
3
VALE icon
Vale
VALE
+$1.96M
4
CQP icon
Cheniere Energy
CQP
+$1.94M
5
STR
Sitio Royalties
STR
+$1.94M

Top Sells

Rank Stock Value
1
BCC icon
Boise Cascade
BCC
+$2.62M
2
EXR icon
Extra Space Storage
EXR
+$2.49M
3
CNQ icon
Canadian Natural Resources
CNQ
+$2.46M
4
IMO icon
Imperial Oil
IMO
+$2.45M
5
AVNT icon
Avient
AVNT
+$2.42M

Sector Composition

Rank Sector Weight
1 Materials 20.16%
2 Real Estate 20.02%
3 Healthcare 16.51%
4 Energy 10.55%
5 Utilities 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNAM
276
DELISTED
Avidity Biosciences
RNAM
$116K 0.05%
6,286
-378
-6% -$6.42K
CLVS
277
DELISTED
Clovis Oncology, Inc.
CLVS
$116K 0.05%
57,437
-3,399
-6% -$6.68K
ABCL icon
278
AbCellera Biologics
ABCL
$1.65B
$115K 0.05%
11,784
-698
-6% -$6.61K
AUTL
279
Autolus Therapeutics
AUTL
$389M
$115K 0.05%
27,536
-1,639
-6% -$6.89K
GTHX
280
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$115K 0.05%
15,188
-900
-6% -$8.54K
VBIV
281
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$115K 0.05%
2,307
-137
-6% -$6.77K
MRSN
282
DELISTED
Mersana Therapeutics
MRSN
$113K 0.05%
1,132
-67
-6% -$7.83K
ABUS icon
283
Arbutus Biopharma
ABUS
$847M
$112K 0.05%
37,448
-2,227
-6% -$6.82K
RAPT
284
DELISTED
RAPT Therapeutics
RAPT
$112K 0.05%
635
-39
-6% -$7.37K
RPTX
285
DELISTED
Repare Therapeutics
RPTX
$112K 0.05%
7,891
-464
-6% -$6.88K
AKRO
286
DELISTED
Akero Therapeutics
AKRO
$111K 0.05%
7,802
-464
-6% -$8.13K
DNLI icon
287
Denali Therapeutics
DNLI
$3.79B
$110K 0.05%
3,433
-200
-6% -$6.88K
HGEN
288
DELISTED
HUMANIGEN, INC.
HGEN
$110K 0.05%
36,572
-2,168
-6% -$5.8K
ALXO icon
289
ALX Oncology
ALXO
$262M
$109K 0.05%
6,465
-379
-6% -$6.47K
RCKT icon
290
Rocket Pharmaceuticals
RCKT
$343M
$108K 0.05%
6,792
-400
-6% -$6.91K
QTTB icon
291
Q32 Bio
QTTB
$435M
$108K 0.05%
1,972
-116
-6% -$7.21K
ALEC icon
292
Alector
ALEC
$169M
$105K 0.05%
7,356
-443
-6% -$7.01K
MGTX icon
293
MeiraGTx Holdings
MGTX
$1.08B
$105K 0.05%
7,579
-453
-6% -$6.98K
TPTX
294
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$105K 0.05%
3,893
-238
-6% -$8K
ARWR icon
295
Arrowhead Research
ARWR
$12.1B
$104K 0.05%
2,258
-142
-6% -$7.03K
CDXS icon
296
Codexis
CDXS
$158M
$104K 0.05%
5,023
-292
-5% -$6.05K
CGEM icon
297
Cullinan Oncology
CGEM
$1.06B
$104K 0.05%
9,941
-595
-6% -$8.04K
FMTX
298
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$104K 0.05%
11,234
-668
-6% -$7.11K
EDIT icon
299
Editas Medicine
EDIT
$399M
$103K 0.05%
5,425
-315
-5% -$5.86K
KNTE
300
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$103K 0.05%
9,184
-541
-6% -$5.96K
10 11
12
13 14

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, Virtus ETF Advisers held 420 positions worth $223M, down 16% from $265M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Virtus ETF Advisers withdrew a net $38.1M in Q1 2022, closing 47 positions and reducing 231 holdings. Its most notable exit was Boise Cascade, an estimated $2.62M position sold in full.

By sector, the portfolio is most concentrated in Materials at 20% of assets, up from 14% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Virtus ETF Advisers opened a new position in The Mosaic Company worth $2.75M.

  • Virtus ETF Advisers's largest Q1 2022 buy was The Mosaic Company: 41,283 shares worth $2.75M.
  • Virtus ETF Advisers added most to Agnico Eagle Mines in Q1 2022, an estimated $1.28M increase.
  • Virtus ETF Advisers's biggest Q1 2022 reduction was Gold Fields, cutting an estimated $1.09M.
  • Virtus ETF Advisers fully exited Boise Cascade in Q1 2022, selling an estimated $2.62M.
  • Virtus ETF Advisers's ten largest holdings make up 11% of its $223M portfolio in Q1 2022.
  • Virtus ETF Advisers opened 44 new positions and closed 47 in Q1 2022.
  • Virtus ETF Advisers's portfolio value fell 16% quarter-over-quarter to $223M.

Based on Virtus ETF Advisers's 13F filing for Q1 2022, filed 16 May 2022.